Cytokeratins 7 and 20: Applications in tumor pathology;Les cytokeratines 7 et 20: Aide au typage des tumeurs

Annales de Pathologie

Volumn 18, Issue 2, 1998, Pages 103-109

  Leroy, X ^a   Copin, M C ^a   Boman, F ^a   Gosselin, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cytokeratin 20; Cytokeratin 7; Immunohistochemistry; Metastasis; Tumour

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; UNCLASSIFIED DRUG; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; CHEMISTRY; NEOPLASM; PATHOLOGY; REVIEW;

HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031977313     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. NAGLE RB. Intermediate filaments: a review of the basic biology. Am J Surg Pathol 1988 ; 12 (suppl 1) : 4-16.
2. SCHAAFSMA HE, RAMAEKERS FCS. Cytokeratin subtyping in normal and neoplastic epithelium : basic principles and diagnostic applications. Pathol Annu 1994 ; 29 : 21-62.
3. NAGLE RB. A review of intermediate filament biology and their use in pathologic diagnosis. Mol Biol Rep 1994 ; 19 : 3-21.
4. MOLL R, FRANKE WW, SCHILLER DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982 ; 31 : 11-24.
5. Moll R. Diversity of cytokeratins in carcinomas. Acta Histochem 1987 ; Suppl 34 : 37-44.
6. HEATLEY MK. Cytokeratins and cytokeratin staining in diagnostic histopathology. Histopathology 1996 ; 28 : 479-83.
7. RAMAEKERS F, VAN NIEKERK C, POELS L, SCHAAFSMA E, HUIJSMANS A, ROBBEN H, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990 ; 136 : 641-55.
8. RAMAEKERS F, HUYSMANS A, SCHAART G, MOESKER O, VOOIJS P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987 ; 170 : 235-49.
9. VAN NIEKERK C, JAP PHK, RAMAEKERS FCS, VAN DE MOLENGRAFT F, POELS LG. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol 1991 ; 165 : 145-52.
10. VAN DE MOLENGRAFT FJM, VAN NIEKERK CC, JAP PHK, POELS LG. OV-TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancer. Histopathology 1993 ; 22 : 35-8.
11. MOLL R, LOWE A, LAUFER J, FRANKE WW. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992 ; 140 : 427-47.
12. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest 1985 ; 52 : 243-56.
13. MIETTINEN M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial. and Merkel cell carcinomas. Mod Pathol 1995 ; 8 : 384-8.
14. CHAN JKC, SUSTER S, WENIG BM, TSANG WYW, CHAN JBK, LAU ALW. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997 ; 21 : 226-34.
15. LOY TS, CALALUCE RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994 ; 102 : 764-7.
16. FUKAI I, MASAOKA A, HASHIMOTO T, YAMAKAWA Y, NIWA H, KIRIYAMA M, et al. Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins. J Thorac Cardiovasc Surg 1995 ; 110 : 1670-5.
17. SAVERA AT, TORRES FX, LINDEN MD, BACCHI CE, GOWN AM, ZARBO RJ, et al. Primary versus metastatic pulmonary adenocarcinoma: an irnmunohistochemical study using villin and cytokeratins 7 and 20. Appl Immunohistochem 1996 ; 4 : 86-94.
18. BLOBEL GA, MOLL R, FRANKE WW, KAYSER KW, GOULD VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 1985 ;121 : 235-47.
19. SAVERA AT, LINDEN MD. Solitary pulmonary nodule: primary lung adenocarcinoma versus metastatic colon carcinoma. Appl Immunohistochem 1995 ; 3 : 272-5.
20. WEISS LM, GELB AB, MEDEIROS LJ. Adult renal epithelial neoplasms. Am J Clin Pathol 1995 ; 103 : 624-35.
21. VAN EYKEN P, SCIOT R, BROCK P, CASTEELS-VAN DAELE M, RAMAEKERS FCS, DESMET VJ. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathologv 1990 ; 77 : 101-7.
22. VAN EYKEN P, DESMET VJ. Cytokeratins and the liver. Liver 1993 ; 13 : 113-22.
23. MAEDA T, KAJIYAMA K, ADACHI E, TAKENAKA K, SOGIMACHI K, TSUNEYOSHI M. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996 ; 9 : 901-9.
24. MAEDA T, ADACHI E, KAJIYAMA K, SUGIMACHI K, TSUNEYOSHI M. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995 ; 26 : 956-64.
25. SCHAAFSMA HE, RAMAEKERS FCS, VAN MUIJEN GNP, LANE EB, LEIGH IM, ROBBEN H, et al. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol 1990 ; 136 : 329-43.
26. SCHAAFSMA HE, RAMAEKERS FCS, VAN MUIJEN GNP, ROBBEN H, LANE EB, LEIGH IM, et al. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract: an immunohistochemical study comparing local tumor and autologous metastases. Am J Pathol 1991 ; 139 : 1389-400.
27. LINDEMAN N, WEIDNER N. Immunohistochemical profile of prostatic and urothelial carcinoma: impact of heat-induced epitope retrieval and presentation of tumors with intermediate features. Appl Immunohistochem 1996 ; 4 : 264-75.
28. HARNDEN P, EARDLEY I, JOYCE AD, SOUTHGATE J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 1996 ; 78 : 870-5.
29. VIEILLEFOND A, PARADIS V, GROS P, BOUVIER R, CROUÉ A, SAINT-ANDRÉ JP. Est-il utile d'isoler parmi les carcinomes du rein, une variante à cellules chromophobes ? Arch Anat Cytol Pathol 1992 ; 40 : 250-54.
30. GERHARZ CD, MOLL R, STORKEL S, RAMP U, THOENES W, GABBERT HE. Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am J Pathol 1993 ; 142 : 851-9.
31. RENSHAW AA, ZHANG H, CORLESS CL, FLETCHER JA, PINS MR. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol 1997 ; 21 : 1203-9.
32. MOLL R, PITZ S, LEVY R, WEIKEL W, FRANKE WW, CZERNOBILSKY B. Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas. Hum Pathol 1991 ; 22 : 989-1001.
33. WAUTERS CCAP, SMEDTS F, GERRITS LGM, BOSMAN FT, RAMAEKERS FCS. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995 ; 26 : 852-5.
34. LOY TS, CALALUCE RD, KEENEY GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996 ; 9 : 1040-4.
35. UEDA G, SAWADA M, OGAWA H, TANIZAWA O, TSUJIMOTO M. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. Gynecol Oncol 1993 ; 57 : 219-23.
36. GUERRIERI C, FRANLUND B, BOERYD B. Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Mod Pathol 1995 ; 8 : 573-6.
37. RONNETT BM, KURMAN RJ, SHMOOKLER BM, SUGARBAKER PH, YOUNG RH. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 1997 ; 21 : 1144-55.
38. SMEDTS F, RAMAEKERS F, LEUBE RE, KEUSER K, LINK M, Voous P. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma. Am J Pathol 1993 ; 142 : 403-12.
39. LEONARD JH, SCHOESSER M, GOODALL A, TOWNSEND E, BELL JR. Cytokeratin 20 expression in Merkel cell carcinoma and small cell carcinoma of the lung. J Surg Pathol 1996 ; 2 : 47-53.
40. BATTLES OE, PAGE DL, JOHNSON JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol 1997 ; 108 : 6-12.
41. DAMJANOV I, OSBORN M, MIETTINEN M. Keratin 7 is a marker for a subset of trophoblastic cells in human germ cell tumors. Arch Pathol Lab Med 1990 ; 114 : 81-3.
42. HAZELBAG HM, MOOI WJ, FLEUREN GJ, HOGENDOORN PCW. Chain-specific keratin profile of epithelioid soft-tissue sarcomas: an immunohistochemical study on synovial sarcoma and epithelioid sarcoma. Appl Immunohistochem 1996 ; 4 : 176-83.